PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc.
Stay updated with breaking news from Jane Hanlon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc.
Advise Wise has launched a webinar series with the Equity Release Council. The initiative is open to all Advise Wise members, with the intention of providing them with a better understanding of the council’s recently launched ‘Advisers 24 points checklist’. In addition, the series offers the opportunity to ask questions directly to the council. The series consists of five weekly live sessions hosted from 4 February by Craig Faulkiner, head of distribution at Advise Wise. It will also feature the participation of Jane Hanlon, mortgage club manager at Advise Wise, Sue Read and Lorraine Co...